- Home
- IDXX
as 04-25-2025 4:00pm EST
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as IDEXX Laboratories Inc. IDXX prepares to release earnings report on 01 May 2025.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | WESTBROOK |
| Market Cap: | 34.1B | IPO Year: | 1991 |
| Target Price: | $523.75 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 10.67 | EPS Growth: | 6.06 |
| 52 Week Low/High: | $356.14 - $548.88 | Next Earning Date: | 05-01-2025 |
| Revenue: | $3,897,504,000 | Revenue Growth: | 6.46% |
| Revenue Growth (this year): | 7.74% | Revenue Growth (next year): | 7.74% |
Stock Insider Trading Activity of IDEXX Laboratories Inc. (IDXX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FENNELL GEORGE | IDXX | Executive Vice President | Feb 7 '25 | Sell | $462.53 | 9,986 | $4,618,861.53 | 8,176 | |
| SZOSTAK M ANNE | IDXX | Director | Feb 7 '25 | Sell | $465.95 | 3,000 | $1,397,835.00 | 3,061 |
Latest IDEXX Laboratories Inc. News
IDXX Breaking Stock News: Dive into IDXX Ticker-Specific Updates for Smart Investing
Morningstar Research
a day ago
Analyst Report: IDEXX Laboratories, Inc.
Zacks
2 days ago
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
Argus Research
3 days ago
IDXX: Raising target price to $443.00
TipRanks
4 days ago
Idexx Laboratories price target lowered to $475 from $535 at BofA
MT Newswires
5 days ago
BofA Trims Price Target on IDEXX Laboratories to $475 From $535, Maintains Neutral Rating
MT Newswires
5 days ago
Leerink Partners Adjusts Price Target on IDEXX Laboratories to $500 From $525, Maintains Outperform Rating
Zacks
5 days ago
IDXX Gears Up for Q1 Earnings: What to Expect From the Stock?
Argus Research
10 days ago
IDXX: Raising target price to $424.00
Compare IDXX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IDXX IDEXX Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.